A 2025 Gallup survey found 12.4% of U.S. adults reported using GLP-1 medications for weight loss in 2025, up from 5.8% who reported such use in February 2024.
January 01, 2025
high
statistical
Self-reported use of GLP-1 class medications for weight loss as measured by Gallup.